drugset / Trial / NCT05997043

Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease

NCT05997043

Phase 0 Unknown 60 enrolled Zhujiang Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized controlled trial is to be conducted to confirm the efficacy and safety of intramuscular injection of botulinum toxin in the treatment of Parkinson's bladder overactivity.

Timeline

Start
2023-08-26
Primary completion
2024-07-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Intramuscular